Analyst Ratings For Eyenovia Inc (NASDAQ:EYEN)
Today, HC Wainwright set its price target on Eyenovia Inc (NASDAQ:EYEN) to $12.00 per share.
There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Eyenovia Inc (NASDAQ:EYEN) is Buy with a consensus target price of $22.3333 per share, a potential 600.10% upside.
Some recent analyst ratings include
- 2/20/2018-Eyenovia Inc (NASDAQ:EYEN) has coverage initiated with a Buy ➝ Buy rating and $35.00 price target
- 2/20/2018-Eyenovia Inc (NASDAQ:EYEN) has coverage initiated with a Buy ➝ Buy rating and $20.00 price target
- On 9/25/2018 Michael M Rowe, VP, bought 800 with an average share price of $4.23 per share and the total transaction amounting to $3,384.00.
- On 9/19/2018 Charles E Iv Mather, Director, bought 4,000 with an average share price of $4.79 per share and the total transaction amounting to $19,160.00.
- On 6/28/2018 John P Gandolfo, CFO, bought 2,000 with an average share price of $5.86 per share and the total transaction amounting to $11,720.00.
- On 6/28/2018 Tsontcho Ianchulev, CEO, bought 6,000 with an average share price of $6.63 per share and the total transaction amounting to $39,780.00.
- On 1/29/2018 Fredric N Eshelman, Director, bought 335,000 with an average share price of $10.00 per share and the total transaction amounting to $3,350,000.00.
About Eyenovia Inc (NASDAQ:EYEN)
Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat, which is in Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Recent Trading Activity for Eyenovia Inc (NASDAQ:EYEN)
Shares of Eyenovia Inc closed the previous trading session at 3.13 up +0.23 7.93% with shares trading hands.